Application of the multicenter automatic defibrillator implantation trial II risk score in a nontrial setting

American Journal of Cardiology

Volumn 112, Issue 4, 2013, Pages 530-532

  Naksuk, Niyada ^a,b   Akkaya, Mehmet ^a,b   Adabag, Selcuk ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER AUTOMATIC DEFIBRILLATOR IMPLANTATION TRIAL; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL;

AGE FACTORS; AGED; AREA UNDER CURVE; ATRIAL FIBRILLATION; BLOOD UREA NITROGEN; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MINNESOTA; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RISK; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84881120288     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.019     Document Type: Article

References (16)

1. I. Goldenberg, A.K. Vyas, W.J. Hall, A.J. Moss, H. Wang, H. He, W. Zareba, S. McNitt, and M.L. Andrews Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
2. A. Barsheshet, A.J. Moss, D.T. Huang, S. McNitt, W. Zareba, and I. Goldenberg Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator J Am Coll Cardiol 59 2012 2075 2079
3. N. Naksuk, K.M. Kunisaki, D.G. Benditt, V. Tholakanahalli, and S. Adabag Implantable cardioverter defibrillators in patients with chronic obstructive pulmonary disease Chest 2013 (in press)
4. A.G. Coumbe, N. Naksuk, M. Newell, P. Somasundaram, D.G. Benditt, and S. Adabag Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block Heart 99 2013 334 338
5. S. Adabag, L.G. Smith, I. Anand, A.K. Berger, and R.V. Luepker Sudden cardiac death in heart failure patients with preserved ejection fraction J Card Fail 18 2012 749 754
6. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
7. J.J. Germano, M. Reynolds, V. Essebag, and M.E. Josephson Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 97 2006 1255 1261
8. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, R. Hatala, E. Fain, M. Gent, and S.J. Connolly Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
9. G. Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann, D. Wojciechowski, Z. Kornacewicz-Jach, B. Sredniawa, G. Lupkovics, F. Hofgärtner, A. Lubinski, M. Rosenqvist, A. Habets, K. Wegscheider, and J. Senges Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
10. A.S. Adabag, B.J. Gersh, T.M. Therneau, S.A. Weston, and V.L. Roger Sudden death after myocardial infarction in the community: role of inter-current cardiac events JAMA 300 2008 2022 2029
11. J.P. Daubert, W. Zareba, D.S. Cannom, S. McNitt, S.Z. Rosero, P. Wang, C. Schuger, J.S. Steinberg, S.L. Higgins, D.J. Wilber, H. Klein, M.L. Andrews, W.J. Hall, and A.J. Moss Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
12. G.K. Larsen, J. Evans, W.E. Lambert, Y. Chen, and M.H. Raitt Shocks burden and increased mortality in implantable cardioverter-defibrillator patients Heart Rhythm 8 2011 1881 1886
13. J.E. Poole, G.W. Johnson, A.S. Hellkamp, J. Anderson, D.J. Callans, M.H. Raitt, R.K. Reddy, F.E. Marchlinski, R. Yee, T. Guarnieri, M. Talajic, D.J. Wilber, D.P. Fishbein, D.L. Packer, D.B. Mark, K.L. Lee, and G.H. Bardy Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 September 4 1009 1017
14. P. Dorian Counterpoint: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias increase mortality Heart Rhythm 9 2012 1158
15. M.O. Sweeney, L. Sherfesee, P.J. DeGroot, M.S. Wathen, and B.L. Wilkoff Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients Heart Rhythm 7 2010 353 360
16. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, and K.K. Holloman Programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients J Am Coll Cardiol 52 2008 541 550